These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9922781)

  • 41. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
    Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
    World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Adjuvant therapy of malignant melanoma].
    Franke W; Neumann NJ; Ruzicka T; Schulte KW
    Praxis (Bern 1994); 2001 Feb; 90(8):301-6. PubMed ID: 11256332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Malignant melanoma].
    Schmid-Wendtner M; Wendtner CM
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2548-50. PubMed ID: 23188634
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapy of cutaneous melanoma].
    Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G
    Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous melanoma: a model to study cancer metastasis.
    Leong SP; Gershenwald JE; Soong SJ; Schadendorf D; Tarhini AA; Agarwala S; Hauschild A; Soon CW; Daud A; Kashani-Sabet M
    J Surg Oncol; 2011 May; 103(6):538-49. PubMed ID: 21480247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
    Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
    Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Wong SL; Faries MB; Kennedy EB; Agarwala SS; Akhurst TJ; Ariyan C; Balch CM; Berman BS; Cochran A; Delman KA; Gorman M; Kirkwood JM; Moncrieff MD; Zager JS; Lyman GH
    J Clin Oncol; 2018 Feb; 36(4):399-413. PubMed ID: 29232171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
    Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
    Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Interferon therapy in malignant melanoma].
    Kokoschka EM; Micksche M
    Wien Med Wochenschr; 1993; 143(16-17):441-2. PubMed ID: 8273369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous melanoma: detecting it earlier, weighing management options.
    Lane JE; Dalton RR; Sangueza OP
    J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
    [No Abstract]   [Full Text] [Related]  

  • 54. Melanoma: is immunotherapy of benefit?
    Faries MB; Morton DL
    Adv Surg; 2003; 37():139-69. PubMed ID: 12953631
    [No Abstract]   [Full Text] [Related]  

  • 55. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
    Denisov LE; Kurdina MI
    Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Malignant melanoma and its therapy: a review.
    Chanda JJ; Callen JP; Stawiski MA
    Cutis; 1979 Jun; 23(6):759-83. PubMed ID: 380931
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L; Helmbold P; Emmert S; Marsch WC
    Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Malignant melanoma. Diagnosis and therapy].
    Schultz ES; Schuler G
    HNO; 2005 Nov; 53(11):928-39. PubMed ID: 16167149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Advances in immunotherapy for metastatic melanoma].
    Oláh J
    Magy Onkol; 2017 Jun; 61(2):132-136. PubMed ID: 28585614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis of thick cutaneous melanoma of the trunk and extremity.
    Coit D; Sauven P; Brennan M
    Arch Surg; 1990 Mar; 125(3):322-6. PubMed ID: 2306180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.